Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report
Keyword(s):
Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 89
(3)
◽
pp. 564-567
◽
2014 ◽
Vol 35
(12)
◽
pp. 2017-2018
◽
Keyword(s):
Keyword(s):